Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,710 total articles
John W. Kozarich, a director at Ligand Pharmaceuticals Inc., executed multiple sales totaling $563,079 worth of the company's common stock during the first half of May. This activity occurred against a backdrop of mixed market signals for LGND; while shares have seen an 112% gain over the last year and some analysts raised earnings forecasts, the c…
MarketWise, Inc. (MKTW) saw notable insider buying when director Frank Porter Stansberry acquired a total of 30,000 shares of Class A Common Stock over two weeks in May 2026. This activity occurred as the stock trades at $17.27, prompting analysis regarding its valuation relative to perceived fair value. Concurrently, the company released its fourt…
A report details a recent stock sale by a director at The Charles Schwab Corporation (SCHW), alongside significant corporate updates. Key findings include the director's sale of shares held through a trust, prior option acquisitions via nonqualified stock options, and broader company data showing increased client assets and new brokerage account op…
Director Bradley Lee Soultz executed multiple transactions selling common stock of WillScot Holdings Corp (WSC) totaling approximately $4,205,565 over the course of May 12 and May 13, 2026. These sales involved both shares held directly by Mr. Soultz and those managed through various trusts. The reported transactions occurred against a backdrop whe…
A director at Abundia Global Impact Group, Inc. recently purchased a substantial amount of the company's common stock. This transaction occurs amidst several significant corporate announcements regarding AGIG, including the scheduling of its 2026 annual stockholder meeting, the successful raising of $20 million from an institutional investor, and p…
Insider activity at Rocket Lab Corp has been reported, noting a substantial sale of common stock shares by director Alexander R. Slusky via an indirect holding structure. This report details the transaction amounts and prices relative to the company's current market performance. Furthermore, recent financial disclosures reveal robust first-quarter …
Innodata Inc. (NASDAQ:INOD) recently saw its CEO and director, Jack Abuhoff, execute substantial sales of common stock between May 12 and May 14, 2026. These transactions totaled approximately $22.8 million, representing a sale of 243,150 shares at prices ranging from $90.20 to $97.66 per share. This activity occurred while the company's stock had …
Protagonist Therapeutics' CEO, Dinesh V. Patel, executed a substantial sale of common stock valued at approximately $7.5 million on May 12, 2026. This transaction followed the exercise of vested stock options under a pre-arranged Rule 10b5-1 plan. The timing is notable as Protagonist Therapeutics (NASDAQ:PTGX) shares are trading near their 52-week …
Abhinav A. Shukla, Chief Technical Officer at Shattuck Labs, Inc., recently sold a block of company shares. This sale occurred against the backdrop of significant stock performance for Shattuck Labs (NASDAQ:STTK) over the past year and positive assessments regarding its drug candidate SL-325 from TD Cowen.
Andrew Bialecki, Co-Chief Executive Officer and director of Klaviyo, Inc. (NASDAQ:KVYO), recently reported a significant stock sale worth approximately $2.92 million on May 12, 2026. This transaction was executed through a prearranged Rule 10b5-1 trading plan. The report details Bialecki's holdings and provides context regarding the company's recen…
Chairman Sardar Biglari, through his associated funds, executed a significant purchase of Biglari Holdings Inc. (BH) Class B common stock between May 12 and May 14, 2026. The buying spree totaled over $13 million for 52,674 shares, occurring shortly after the stock experienced a notable decline. This insider activity takes place against a backdrop …
Multiple key stakeholders, including North Run Strategic Opportunities Fund I, LP, director Thomas B. Ellis, and member Todd B. Hammer, sold a total of 293,052 shares of LightPath Technologies' Class A Common Stock between May 12 and May 14, 2026, netting approximately $3.57 million. This selling activity occurs following substantial gains for the …
Recent SEC filings reveal that Maciej Kurzymski, Chief Accounting Officer of Bloom Energy Corp., engaged in notable stock transactions. The sale of over $1.8 million in Class A Common Stock occurred amidst strong market performance and subsequent analyst upgrades following the company's recent quarterly report.
Arundathy N. Pandite, Chief Medical Officer at Shattuck Labs, Inc., recently executed a sale of company stock through a prearranged trading plan. This transaction occurred amidst significant stock appreciation and positive developments regarding the company's lead drug candidate. Furthermore, TD Cowen has maintained a Buy rating for Shattuck Labs f…
James H. Litinsky, the chairman and CEO of MP Materials Corp., executed multiple sales totaling approximately $19.6 million worth of shares over two days in May 2026. These transactions occurred while the company's stock was trading below recent highs. Despite the insider selling activity, MP Materials recently reported strong first-quarter financi…
Linkhome Holdings Inc.'s (NASDAQ:LHAI) recent filings reveal significant insider activity involving CEO and Chairman Zhen Qin, who disposed of common stock through private transfers in January and March 2026. These transactions occurred at a price notably higher than the current market valuation. Separately, the company announced a definitive agree…
The Chief Financial Officer of GSI Technology Inc., Douglas Schirle, recently sold 40,000 shares of common stock. This transaction occurred following his acquisition of an equal number of shares through the exercise of vested options. These movements take place as GSI Technology reports mixed financial results for fiscal year 2026, noting revenue i…
Ping Tak Wu, a Vice President at GSI Technology Inc., executed a sale of common stock shares. This transaction occurred after the company's stock experienced significant gains over the previous week and a substantial increase over the past year. Furthermore, recent earnings reports showed revenue growth for both Q4 fiscal 2026 and the full fiscal y…
Fairfax Financial Holdings Ltd. and its Chief Executive Officer, Prem Watsa, acquired a combined total of 44,179,216 Class A Common Shares of Under Armour Inc. over three days in May 2026. These purchases occurred while the stock was trading at levels significantly below some valuation estimates, despite recent negative market reactions to the comp…
A recent SEC filing disclosed that Candace Jackson, a Senior Vice President at Silvaco Group, sold common stock. This transaction occurred against a backdrop of the company's first-quarter fiscal 2026 earnings report, which showed revenue growth but missed analyst expectations for earnings per share (EPS). The firm also announced an expansion of it…
The reported transaction details show that the spouse of GSI Technology's CEO sold a portion of acquired shares. This activity occurs against a backdrop of significant recent stock gains and mixed financial results, including increased annual revenue but a quarterly net loss per share. Investors are evaluating these factors to determine future valu…
A director at Intrepid Potash, Inc. executed a stock sale totaling $217,149. This transaction occurs as the company's shares have seen significant appreciation over six months. Meanwhile, Intrepid Potash released first-quarter 2026 financial results that substantially beat analyst expectations across both earnings per share and revenue.
Robert J. Park, Senior Vice President and Chief Financial Officer of Dolby Laboratories, Inc., sold shares of Class A Common Stock on May 12, 2026. This sale was executed through a pre-arranged Rule 10b5-1 trading plan. The report also details the company's recent Q2 2026 earnings, which surpassed both revenue and EPS forecasts.
Keith A. Meister, a director at Illumina, Inc., recently reported selling approximately $47.9 million worth of common stock over May 13 and May 14, 2026. These transactions were executed through investment funds, while simultaneously, the Corvex Funds completed complex equity swap settlements. The reporting period coincided with strong market activ…
A director at Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), recently sold a portion of the company's common stock. This activity occurred alongside positive financial disclosures for the second quarter of fiscal year 2026, where both revenue and earnings surpassed analyst forecasts. Despite strong operational performance reported in Q2 2026, the c…
